Surrey researchers Sign in
Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with st-Elevation myocardial infarction of de novo lesions?
Journal article   Peer reviewed

Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with st-Elevation myocardial infarction of de novo lesions?

L Belle, M Mahmoudi, C Delhaye, I Ben-Dor, G Maluenda, MA Gaglia, R Torguson, LF Satler, AD Pichard and R Waksman
J Interv Cardiol, Vol.24(4), pp.320-325
08/2011

Abstract

Aged Angioplasty Balloon Coronary Cohort Studies Coronary Artery Disease Coronary Thrombosis Creatine Kinase Drug-Eluting Stents Female Humans Male Middle Aged Myocardial Infarction Prognosis Retrospective Studies Troponin I
Despite significant advances in stent technology and pharmacotherapy, drug-eluting stent thrombosis (DES-ST) remains a major complication of percutaneous coronary intervention (PCI) and commonly presents as ST-elevation myocardial infarction (STEMI). There are currently little data comparing the in-hospital outcomes of patients presenting with STEMI due to DES-ST with those due to de novo coronary artery disease (CAD).

Metrics

Details

Usage Policy